Cortellis Product Intelligence

Your trusted source to build a more resilient supply chain

Make timely and data-driven business decisions with a comprehensive, single source of market performance, patent and manufacturing data.

  • Track 85k+ companies, including API and dose manufacturers, across the global supply chain.
  • Access 26k+ SPCs to map exclusivity timelines and support market entry planning.
  • Analyze sales and volume data for 63k+ molecules to forecast demand and sourcing needs.
  • Explore 1.4m+ patents, SPCs, and litigation records to uncover IP risks and opportunities.

Request more information

Optimize global pricing and market access with confidence

Strengthen your pricing strategy with global reimbursement and pricing trends for final dose formulations in 90+ markets. Access up to 5 years of historical market share and reimbursement data for the US and LATAM to anticipate payer pressure and support informed portfolio decisions.

Why business development, portfolio, IP, and sourcing experts trust CPI

Accurately forecast loss of exclusivity

Identify generic entry timing with insights from 26k+ SPCs and 1.4m+ patents, including litigation and exclusivity data.

Drive informed launch planning

Plan smarter with global data on 85k+ companies and 63k+ molecules, supported by sales, pricing, and market share trends.

Gain insight into biopharma pricing dynamics

Understand pricing and reimbursement trends with access to robust historical data and 18.5k+ synthesis schemes.

Ready to make faster, smarter decisions by unlocking critical product and market intelligence?

Never miss a launch window with timely LOE intelligence

Pinpoint the earliest generic entry dates by analyzing patents and exclusivities. Uncover new launch opportunities with 50+ criteria on LOE and market potential, supported by timely patent, manufacturing, and performance updates—all in one trusted solution.

 

[Cortellis Product Intelligence] provides a wide range of information in one place, which is otherwise difficult to obtain. [It] saves substantial time and, at the same time, provides a thorough picture on the topics.

Head of Patents Global CDMO and API manufacturer company

When we plan [our] generic portfolio to enter U.S. and E.U. markets, we survey information on Cortellis Product Intelligence.

IP Analyst Global pharmaceutical company focused on biosimilars

This platform is a one-stop shop for commercial as well as competitive information. It saves considerable time, it’s easy to navigate, it’s easy to download and use information as desired, and hence, it’s a productive and progressive tool for an organization.”

Business Development and Licensing Top 20 pharmaceutical company

[Cortellis Product Intelligence] is one of the greatest tools for us to manage our suppliers in API business. [It] provides unique and serious data for those who are responsible in supply management, control and new product development.”

Managing Director – Asia Pacific US-based pharmaceutical company

We have had [Cortellis Product Intelligence] for over 15 years. With competition at an all-time high, you need a place with direct information in one spot.

Business Development and Licensing Pharmaceutical company

Building and continually monitoring a differentiated product portfolio is critical for us, and Clarivate has helped us do just that, which is essential to our growth.

Chairman and CEO Pharmaceutical company

chevron_left
chevron_right

Have questions?

Our experts are here to help.

Request more information